Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott’s Humira discount

Executive Summary

The average sales price of Abbott's rheumatoid arthritis treatment Humira (adalimumab) is about 8% below its listed wholesale acquisition cost, Centers for Medicare & Medicaid Services data indicates. The Humira wholesale acquisition cost is $605.39 per 40 mg dose, according to Red Book. The average sales price of $555.91 per 40 mg is based on CMS' published second quarter Medicare Part B payment limit. Although the product is not reimbursed under Part B, average sales price data is reported for adalimumab because it is assigned a J-code, Abbott said...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel